review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Jonathan Guito | |
David Lukac | |||
P2860 | cites work | Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. | Q36933894 |
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease | Q36945537 | ||
Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease | Q36983763 | ||
Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program | Q37060535 | ||
Identification of cellular genes targeted by KSHV-encoded microRNAs | Q21131610 | ||
Identification of a novel kinesin-related protein, KRMP1, as a target for mitotic peptidyl-prolyl isomerase Pin1 | Q24291480 | ||
Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC | Q24291638 | ||
The F-box protein FBX4 targets PIN2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance | Q24293991 | ||
Characterization and cell cycle regulation of the related human telomeric proteins Pin2 and TRF1 suggest a role in mitosis | Q24311518 | ||
The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer | Q24317638 | ||
The structure and function of proline-rich regions in proteins | Q24528663 | ||
Human herpesvirus 8--a novel human pathogen | Q24530670 | ||
Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. | Q24535558 | ||
Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis | Q24540581 | ||
Slow peptide bond formation by proline and other N-alkylamino acids in translation | Q24646781 | ||
Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization | Q24648127 | ||
Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins | Q26825421 | ||
Kaposi's sarcoma-associated herpesvirus ORF45 interacts with kinesin-2 transporting viral capsid-tegument complexes along microtubules | Q27317383 | ||
Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent | Q27739821 | ||
Notch signaling: cell fate control and signal integration in development | Q27861061 | ||
Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. | Q27863922 | ||
All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae | Q27937279 | ||
A human peptidyl-prolyl isomerase essential for regulation of mitosis | Q28117639 | ||
The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9 | Q28189143 | ||
Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage | Q28208518 | ||
Pinning down proline-directed phosphorylation signaling | Q28215887 | ||
Principles that govern the folding of protein chains | Q28236872 | ||
Phosphorylation-specific prolyl isomerization: is there an underlying theme? | Q28248256 | ||
Prolyl cis-trans isomerization as a molecular timer | Q28249249 | ||
Primary effusion lymphoma | Q28303700 | ||
KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA | Q28474913 | ||
An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors. | Q30319745 | ||
Novel mode of phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human cytomegalovirus | Q30494221 | ||
Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation | Q30570559 | ||
Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus. | Q30919397 | ||
P53 facilitates degradation of human T-cell leukaemia virus type I Tax-binding protein through a proteasome-dependent pathway | Q31136167 | ||
Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro | Q33234751 | ||
EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus | Q33415884 | ||
KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia | Q33509506 | ||
Molecular biology of KSHV in relation to AIDS-associated oncogenesis | Q33560572 | ||
Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts | Q33608244 | ||
KSHV-induced notch components render endothelial and mural cell characteristics and cell survival | Q33627013 | ||
High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations | Q33647633 | ||
Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression | Q33653424 | ||
The Ess1 prolyl isomerase: traffic cop of the RNA polymerase II transcription cycle | Q33726010 | ||
Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway | Q33737793 | ||
Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis | Q33842738 | ||
DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters | Q33844093 | ||
CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50 | Q33854980 | ||
Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency | Q33923893 | ||
Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation | Q33934864 | ||
Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes | Q34009230 | ||
A viral nuclear noncoding RNA binds re-localized poly(A) binding protein and is required for late KSHV gene expression | Q34055296 | ||
Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML | Q34072688 | ||
beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA | Q34092690 | ||
Convergence of Kaposi's Sarcoma-Associated Herpesvirus Reactivation with Epstein-Barr Virus Latency and Cellular Growth Mediated by the Notch Signaling Pathway in Coinfected Cells | Q34178226 | ||
Pinning down cell signaling, cancer and Alzheimer's disease | Q34313141 | ||
Gamma-herpesviruses and cellular signaling in AIDS-associated malignancies | Q36886330 | ||
Catalysis of protein folding by parvulin | Q36889249 | ||
A mobile functional region of Kaposi's sarcoma-associated herpesvirus ORF50 protein independently regulates DNA binding and protein abundance | Q36898798 | ||
Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. | Q37093134 | ||
Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB | Q37127860 | ||
Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA. | Q37144643 | ||
NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. | Q37157187 | ||
Pin1 promotes histone H1 dephosphorylation and stabilizes its binding to chromatin | Q37233602 | ||
Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus | Q37273424 | ||
Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis | Q37307209 | ||
MicroRNAs of Kaposi's sarcoma-associated herpes virus | Q37327019 | ||
Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation | Q37356550 | ||
The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency | Q37380228 | ||
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus. | Q37397204 | ||
Role of ORF74-encoded viral G protein-coupled receptor in human herpesvirus 8 lytic replication | Q37452466 | ||
The prolyl isomerase pin1 regulates mRNA levels of genes with short half-lives by targeting specific RNA binding proteins | Q37458768 | ||
Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus | Q37475295 | ||
Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication | Q37476243 | ||
Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis | Q37485770 | ||
KSHV Rta Promoter Specification and Viral Reactivation | Q37986049 | ||
Tegument Proteins of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses | Q37995595 | ||
Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update | Q38114627 | ||
Cyclophilins as modulators of viral replication | Q38121470 | ||
X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency | Q38297437 | ||
Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells | Q38348410 | ||
Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. | Q38359222 | ||
Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway | Q38761166 | ||
Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL. | Q38959859 | ||
Phosphorylation of human immunodeficiency virus type 1 capsid protein at serine 16, required for peptidyl-prolyl isomerase-dependent uncoating, is mediated by virion-incorporated extracellular signal-regulated kinase 2. | Q39025822 | ||
The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency | Q39068717 | ||
Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication. | Q39230419 | ||
Pin1 modulates RNA polymerase II activity during the transcription cycle | Q39258906 | ||
Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression | Q39323907 | ||
Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities | Q39590466 | ||
Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells | Q39596534 | ||
Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication | Q39603164 | ||
Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1. | Q39696042 | ||
Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. | Q34338900 | ||
Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis | Q34353633 | ||
Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients | Q34382472 | ||
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. | Q34408877 | ||
Molecular chaperones in protein quality control | Q34424856 | ||
Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies | Q34653644 | ||
Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy | Q34683604 | ||
Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines | Q34733560 | ||
Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma | Q34764819 | ||
The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro | Q35005190 | ||
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation | Q35010647 | ||
Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia | Q35019982 | ||
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis | Q35026060 | ||
Prevalent overexpression of prolyl isomerase Pin1 in human cancers | Q35097986 | ||
Structure and function of latency-associated nuclear antigen | Q35124429 | ||
Never say never. The NIMA-related protein kinases in mitotic control | Q35125628 | ||
Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis | Q35127940 | ||
Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling | Q35168476 | ||
The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression | Q35196615 | ||
Post-Translational Modifications of Kaposi's Sarcoma-Associated Herpesvirus Regulatory Proteins - SUMO and KSHV | Q35755464 | ||
Ser-634 and Ser-636 of Kaposi's Sarcoma-Associated Herpesvirus RTA are Involved in Transactivation and are Potential Cdk9 Phosphorylation Sites | Q35770298 | ||
KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts | Q35810446 | ||
Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis | Q35841060 | ||
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramer | Q35857736 | ||
Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? | Q35885806 | ||
Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein | Q36019173 | ||
Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks. | Q36044701 | ||
Suppressive regulation of KSHV RTA with O-GlcNAcylation | Q36092308 | ||
Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein | Q36315189 | ||
The unfolded protein response: a novel component of the hypoxic stress response in tumors. | Q36326570 | ||
The interaction between KSHV RTA and cellular RBP-Jkappa and their subsequent DNA binding are not sufficient for activation of RBP-Jkappa | Q36427142 | ||
Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency | Q36538689 | ||
Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency | Q36540187 | ||
Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription | Q36684599 | ||
PIN1 gene overexpression and beta-catenin gene mutation/expression in hepatocellular carcinoma and their significance. | Q53335167 | ||
TPA-induced cell transformation provokes a complex formation between Pin1 and 90 kDa ribosomal protein S6 kinase 2. | Q54512822 | ||
Prolyl isomerases do not catalyze isomerization of non-prolyl peptide bonds | Q74490362 | ||
Pinning down transcription: regulation of RNA polymerase II activity during the cell cycle | Q75320782 | ||
Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein | Q77760836 | ||
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes | Q78860218 | ||
The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation | Q81304838 | ||
Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation | Q39763904 | ||
Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression | Q39813847 | ||
The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma | Q39814307 | ||
Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression | Q39819343 | ||
X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions | Q39858771 | ||
The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. | Q39860135 | ||
Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway | Q39860632 | ||
Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance | Q39908170 | ||
Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein | Q39992227 | ||
Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells | Q40009835 | ||
Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication | Q40021229 | ||
Hypoxia and the unfolded protein response. | Q40053046 | ||
Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling. | Q40112910 | ||
Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivati | Q40126113 | ||
The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus | Q40149571 | ||
Poly(ADP-Ribose) Polymerase 1 and Ste20-Like Kinase hKFC Act as Transcriptional Repressors for Gamma-2 Herpesvirus Lytic Replication | Q40172406 | ||
Pin1 modulates the structure and function of human RNA polymerase II. | Q40266169 | ||
Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro | Q40267803 | ||
Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency | Q40279784 | ||
The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. | Q40333151 | ||
Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer | Q40358876 | ||
Kaposi's Sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3. | Q40763723 | ||
Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus | Q40807418 | ||
Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses. | Q40815022 | ||
Protein folding. Prolyl isomerases join the fold | Q40935542 | ||
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. | Q41839438 | ||
The zinc finger DNA-binding domain of K-RBP plays an important role in regulating Kaposi's sarcoma-associated herpesvirus RTA-mediated gene expression | Q41906267 | ||
Pinning down viral proteins: a new prototype for virus-host cell interaction | Q42005266 | ||
Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression | Q42020447 | ||
Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | Q42049779 | ||
A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication | Q42150768 | ||
Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of c-fos mRNA by the protein kinase A inhibitor N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide | Q42809475 | ||
Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function | Q43809033 | ||
Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections | Q43895475 | ||
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. | Q44192183 | ||
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. | Q44618217 | ||
The prolyl isomerase Pin1 interacts with and downregulates the activity of AMPK leading to induction of tumorigenicity of hepatocarcinoma cells | Q44785984 | ||
Hepatitis B virus x protein and pin1 in liver cancer: "les liaisons dangereuses". | Q45405874 | ||
Actin-binding cellular proteins inside human immunodeficiency virus type 1. | Q45745422 | ||
Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. | Q46029178 | ||
The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation. | Q46147838 | ||
Moritz Kaposi: idiopathic pigmented sarcoma of the skin | Q46168427 | ||
Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells | Q46531701 | ||
LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma. | Q47684034 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | transcription factor | Q407384 |
regulation of gene expression | Q411391 | ||
viral protein | Q952587 | ||
virus | Q808 | ||
DNA-binding protein | Q2252764 | ||
virus latency | Q4115619 | ||
enzyme | Q8047 | ||
trans-activators | Q67206335 | ||
host microbial interaction | Q68260314 | ||
viral gene expression regulation | Q70682269 | ||
immediate-early proteins | Q77944262 | ||
P304 | page(s) | 72-109 | |
P577 | publication date | 2015-01-12 | |
P1433 | published in | Viruses | Q7935305 |
P1476 | title | KSHV reactivation and novel implications of protein isomerization on lytic switch control | |
P478 | volume | 7 |
Q38865828 | Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. |
Q26766493 | Co-infections and Pathogenesis of KSHV-Associated Malignancies |
Q40064939 | Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage. |
Q90434397 | Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation |
Q38735096 | Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential. |
Q56941539 | K15 Protein of Kaposi's Sarcoma Herpesviruses Increases Endothelial Cell Proliferation and Migration through Store-Operated Calcium Entry |
Q41662283 | KSHV and the Role of Notch Receptor Dysregulation in Disease Progression |
Q45183417 | KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation |
Q26825783 | Modulation of DNA damage and repair pathways by human tumour viruses |
Q40149921 | Modulation of global SUMOylation by Kaposi's sarcoma-associated herpesvirus and its effects on viral gene expression. |
Q59353945 | Molecular mechanisms of viral oncogenesis in humans |
Q40144368 | Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma |
Q36252859 | Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency |
Q38716029 | RTA Occupancy of the Origin of Lytic Replication during Murine Gammaherpesvirus 68 Reactivation from B Cell Latency. |
Q39284842 | Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update |
Q99591124 | Regulation of KSHV Latency and Lytic Reactivation |
Q26799398 | The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review) |
Q40077951 | The replication and transcription activator of murine gammaherpesvirus 68 cooperatively enhances cytokine-activated, STAT3-mediated gene expression. |